Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
184.80 SEK | -0.48% |
|
+3.41% | -7.37% |
17/06 | Lannebo Sverige Plus increased by 4.3 percent in May – rising profitability at Elekta | FW |
13/06 | BioArctic to Advance Parkinson's Disease Drug Trial After Positive Safety Review | MT |
Main competitors
Consensus (Composite) | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
SEK 289.4 | +55.84% | 5 | |||||||
CHF 658.11 | +17.94% | 22 | |||||||
₩2,15,152.97 | +20.33% | 22 | |||||||
$330.95 | +37.33% | 23 | |||||||
$189.65 | +16.75% | 19 | |||||||
€59.73 | -0.91% | 14 | |||||||
$175.2 | +18.71% | 15 | |||||||
$195.94 | +30.64% | 16 | |||||||
$50.35 | +5.94% | 15 | |||||||
$66.7 | +14.98% | 10 | |||||||
$300.2 | -5.87% | 12 | |||||||
$130.6 | +1.71% | 15 | |||||||
$67.28 | +30.55% | 13 | |||||||
$156.14 | +1.46% | 17 | |||||||
$72.91 | +98.82% | 11 | |||||||
$57.89 | +38.55% | 26 | |||||||
CN¥53.6 | +1.16% | 13 | |||||||
CN¥29.91 | +24.94% | 11 | |||||||
Average | 12,113.2 | +22.72% | 16 | ||||||
Weighted average by Cap. | 25,058.37 | +20.57% | 18 |
- Stock Market
- Equities
- BIOA B Stock
- Sector BioArctic AB
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition